The store will not work correctly when cookies are disabled.
(2R,3S,4S,6R)-2-(hydroxymethyl)-6-propylpiperidine-3,4-diol
ID: ALA208589
PubChem CID: 44411974
Max Phase: Preclinical
Molecular Formula: C9H19NO3
Molecular Weight: 189.25
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCC[C@@H]1C[C@H](O)[C@@H](O)[C@@H](CO)N1
Standard InChI: InChI=1S/C9H19NO3/c1-2-3-6-4-8(12)9(13)7(5-11)10-6/h6-13H,2-5H2,1H3/t6-,7-,8+,9+/m1/s1
Standard InChI Key: WOGVMZZLDYFJIE-HXFLIBJXSA-N
Molfile:
RDKit 2D
13 13 0 0 1 0 0 0 0 0999 V2000
1.6656 2.0392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6656 1.2142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3774 0.8056 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0891 1.2142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0891 2.0392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3774 2.4557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8031 0.8008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8047 2.4497 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3774 3.2807 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.9517 0.8008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8021 -0.0242 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.2367 1.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4774 0.7991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 7 1 1
1 2 1 0
5 8 1 1
1 6 1 0
6 9 1 6
2 3 1 0
2 10 1 6
3 4 1 0
7 11 1 0
4 5 1 0
10 12 1 0
5 6 1 0
12 13 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 189.25 | Molecular Weight (Monoisotopic): 189.1365 | AlogP: -0.77 | #Rotatable Bonds: 3 |
Polar Surface Area: 72.72 | Molecular Species: BASE | HBA: 4 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.43 | CX Basic pKa: 8.91 | CX LogP: -0.81 | CX LogD: -2.32 |
Aromatic Rings: ┄ | Heavy Atoms: 13 | QED Weighted: 0.47 | Np Likeness Score: 2.65 |
References
1. Pearson MS, Saad RO, Dintinger T, Amri H, Mathé-Allainmat M, Lebreton J.. (2006) Flexible synthesis and biological evaluation of novel 5-deoxyadenophorine analogues., 16 (12): [PMID:16603357] [10.1016/j.bmcl.2006.03.035] |